title: Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin.
abstract: This study was designed to evaluate the in vivo effect of magnolol and honokiol on the acute phase of coronary ligation in the presence of nitric oxide inhibitor (L-NAME) or cyclooxygenase inhibitor (aspirin). After Sprague-Dawley rats were anesthetized with urethane, the changes of ventricular arrhythmia induced by coronary ligation for 30 min were determined with or without pretreatment with study medications. The incidence and duration of ventricular arrhythmia were significantly reduced after intravenous pretreatment (15 min before coronary ligation) with 10(-7) g/kg magnolol or 10(-7) g/kg honokiol. However, the antiarrhythmic effect of magnolol or honokiol could be abolished with the pretreatment of 1 mg/kg L-NAME, but not with pretreatment of 100 mg/kg aspirin. The abolishment of the myocardial beneficial effect of magnolol and honokiol by L-NAME, instead of aspirin, suggests an involvement of an increased nitric oxide synthesis in the protection offered by magnolol and honokiol against arrhythmia during myocardial ischemia.
authors.affiliation: Department of Anesthesiology, National Taiwan University, College of Medicine and Hospital, Taipei, Taiwan. sktsai@ha.mc.ntu.edu.tw
authors.forename: S K
authors.initials: SK
authors.lastname: Tsai
authors.forename: C H
authors.initials: CH
authors.lastname: Huang
authors.forename: S S
authors.initials: SS
authors.lastname: Huang
authors.forename: L M
authors.initials: LM
authors.lastname: Hung
authors.forename: C Y
authors.initials: CY
authors.lastname: Hong
mesh_terms: D000758:Anesthesia; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D001241:Aspirin / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D017705:Lignans; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D051381:Rats; D017207:Rats, Sprague-Dawley; D000498:Allyl Compounds; D010636:Phenols
chemical_list: D000889:Anti-Arrhythmia Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin; D001713:Biphenyl Compounds; D004791:Enzyme Inhibitors; D017705:Lignans; D019331:NG-Nitroarginine Methyl Ester; D019001:Nitric Oxide Synthase; C005498:magnolol; C005499:honokiol; D000498:Allyl Compounds; D010636:Phenols